23Nov
17Nov
Pixability Launches New Contextual Solution to Solve for Transparency and Brand Suitability on Connected TV
Pixability, the only provider of software and insights for video advertising on YouTube and other leading connected TV (CTV) platforms, today announced the launch of a new contextual data solution for CTV. Read more >>
16Nov
Novel Bone Adhesive to Fly on SpaceX CRS-26
More than 200 million people worldwide are affected by osteoporosis, a crippling bone disease that decreases bone density, causing bones to weaken and become increasingly susceptible to fracture. Researchers from RevBio, a biomedical startup, are turning to the microgravity environment of the International Space Station (ISS) National Laboratory to further the development of a novel therapeutic that could help repair bone fractures. Read more >>
04Nov
Pyramid Biosciences to Present at the 2022 Jefferies London Healthcare Conference
Pyramid Biosciences, Inc., a privately-held, clinical-stage biotechnology company focused on developing new and highly differentiated precision therapies for cancer and other serious diseases, announced today that Chief Executive Officer, Brian Lestini, M.D., Ph.D., will present at the 2022 Jefferies London Healthcare Conference on Thursday, November 17, 2022 at 2:40 PM GMT. Read more >>
02Nov
Akston Biosciences Announces Positive Interim Phase II Results from COVID “Universal” Booster Vaccine Trial
Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, today announced top-line clinical results for its Phase II COVID-19 “universal” booster vaccine, AKS-452. An interim analysis of the data found that 93% of subjects previously vaccinated with Pfizer, Moderna, Johnson & Johnson (Janssen), and AstraZeneca vaccines showed an increase in neutralizing antibody titers after receiving a single dose of AKS-452. The average neutralization titers across all subjects increased 4-fold against the Wuhan strain and 5-fold against the Omicron...
28Oct
Legally blind man can see 20/20 vision again and inspires others with his story
More than 280,000 Ohioans are considered legally blind. Luckily for some, there are medical devices available to help correct their vision. Aside from it being extremely expensive getting a pair of these glasses, which is through the company, 'eSight', Benjamin Murray explained being legally blind comes with a long list of challenges in itself. "You know, it's hard to think about everyday life when you can't see," 33-year-old Murray said. He was considered legally blind for 26 years. In 2015,...
26Oct
U.S. Senator Richard Blumenthal (D-CT) Tours Landsdowne Labs
“Children swallow button batteries. That’s the reality of our world. Because the batteries become loose from devices, and then can literally burn through the throat of a young child. It happens again and again…[leading to] years of treatment, surgery, and therapy.” So said U.S. Senator Richard Blumenthal, D-CT, on an October 7 visit to Landsdowne Labs, at Fairfield University, in Fairfield, CT. Link to video of remarks. Landsdowne has since received a patent for technology that rapidly reduces chemical reactions...
20Oct
Meet The New Unicorns Minted In September 2022
Twelve companies joined The Crunchbase Unicorn Board in September 2022, adding $19.6 billion in value to the board. These companies have raised $3.8 billion total in funding with 62% of that amount raised in September 2022. Wasabi on list. Read more >>
20Oct
CleanFiber seeks approval for expansion project in Hamburg
CleanFiber Buffalo – which won $500,000 in the state-funded business-plan competition in 2016 as UltraCell – is planning to construct a 5,250-square-foot metal panel addition to its existing 60,000-square-foot masonry-and-panel building at 250 Lake Ave., bringing the total size to 66,000 square feet. That will give the company more room for material handling, as well as new equipment, as part of what CEO Jonathan Strimling described as a $15 million investment in the facility. The project will be reviewed at...
15Oct